AAAAAA

   
Results: 1-15 |
Results: 15
EVOLUTIONARY PATTERN OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION AND DISTRIBUTION IN LYMPH-NODES FOLLOWING PRIMARY INFECTION - IMPLICATIONS FOR ANTIVIRAL THERAPY
Authors: PANTALEO G COHEN OJ SCHACKER T VACCAREZZA M GRAZIOSI C RIZZARDI GP KAHN J FOX CH SCHNITTMAN SM SCHWARTZ DH COREY L FAUCI AS
Citation: G. Pantaleo et al., EVOLUTIONARY PATTERN OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) REPLICATION AND DISTRIBUTION IN LYMPH-NODES FOLLOWING PRIMARY INFECTION - IMPLICATIONS FOR ANTIVIRAL THERAPY, Nature medicine, 4(3), 1998, pp. 341-345
EXPERIENCE WITH A CROSS-STUDY END-POINT REVIEW COMMITTEE FOR AIDS CLINICAL-TRIALS
Authors: GREEN LA RHAME FS PRICE RW PERLMAN DC CAPPS LG SAMPSON JH DEYTON LR SCHNITTMAN SM FISHER EJ BARTSCH GE KRUM EA NEATON JD
Citation: La. Green et al., EXPERIENCE WITH A CROSS-STUDY END-POINT REVIEW COMMITTEE FOR AIDS CLINICAL-TRIALS, AIDS, 12(15), 1998, pp. 1983-1990
ZIDOVUDINE TREATMENT IN PATIENTS WITH PRIMARY (ACUTE) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: NIU MT BETHEL J HOLODNIY M STANDIFORD HC SCHNITTMAN SM
Citation: Mt. Niu et al., ZIDOVUDINE TREATMENT IN PATIENTS WITH PRIMARY (ACUTE) HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, The Journal of infectious diseases, 178(1), 1998, pp. 80-91
PRELIMINARY EVIDENCE FOR PARTIAL RESTORATION OF IMMUNE FUNCTION IN HIV TYPE-1 INFECTION WITH POTENT ANTIRETROVIRAL THERAPIES - CLUES FROM THE 4TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC DISEASES
Authors: SCHNITTMAN SM FOX L
Citation: Sm. Schnittman et L. Fox, PRELIMINARY EVIDENCE FOR PARTIAL RESTORATION OF IMMUNE FUNCTION IN HIV TYPE-1 INFECTION WITH POTENT ANTIRETROVIRAL THERAPIES - CLUES FROM THE 4TH CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC DISEASES, AIDS research and human retroviruses, 13(10), 1997, pp. 815-818
POTENTIAL ROLE OF LAMIVUDINE (3TC) IN THE CLEARANCE OF CHRONIC HEPATITIS-B VIRUS-INFECTION IN A PATIENT COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: SCHNITTMAN SM PIERCE PF
Citation: Sm. Schnittman et Pf. Pierce, POTENTIAL ROLE OF LAMIVUDINE (3TC) IN THE CLEARANCE OF CHRONIC HEPATITIS-B VIRUS-INFECTION IN A PATIENT COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Clinical infectious diseases, 23(3), 1996, pp. 638-639
OPTIC DISK EDEMA AS THE PRESENTING SIGN OF LYME-DISEASE
Authors: SCHNITTMAN SM PIERCE PF
Citation: Sm. Schnittman et Pf. Pierce, OPTIC DISK EDEMA AS THE PRESENTING SIGN OF LYME-DISEASE, Clinical infectious diseases, 23(3), 1996, pp. 639-640
ANTIRETROVIRAL THERAPY STATE-OF-THE-ART - REVIEW AND RECOMMENDATIONS
Authors: SCHNITTMAN SM
Citation: Sm. Schnittman, ANTIRETROVIRAL THERAPY STATE-OF-THE-ART - REVIEW AND RECOMMENDATIONS, AIDS, 10, 1996, pp. 21-21
A PHASE-I STUDY OF INTERFERON-ALPHA-2B IN COMBINATION WITH INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: SCHNITTMAN SM VOGEL S BASELER M LANE HC DAVEY RT
Citation: Sm. Schnittman et al., A PHASE-I STUDY OF INTERFERON-ALPHA-2B IN COMBINATION WITH INTERLEUKIN-2 IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The Journal of infectious diseases, 169(5), 1994, pp. 981-989
CD8(-LYMPHOCYTES BECOME INFECTED IN-VITRO IN THE PROCESS OF KILLING HIV-1-INFECTED TARGET-CELLS() CYTOLYTIC T)
Authors: DEMARIA A COLOMBINI S SCHNITTMAN SM MORETTA L
Citation: A. Demaria et al., CD8(-LYMPHOCYTES BECOME INFECTED IN-VITRO IN THE PROCESS OF KILLING HIV-1-INFECTED TARGET-CELLS() CYTOLYTIC T), European Journal of Immunology, 24(3), 1994, pp. 531-536
IMMUNE-BASED THERAPEUTICS - SCIENTIFIC RATIONALE AND THE PROMISING APPROACHES TO THE TREATMENT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTEDINDIVIDUAL
Authors: STEIN DS TIMPONE JG GRADON JD KAGAN JM SCHNITTMAN SM
Citation: Ds. Stein et al., IMMUNE-BASED THERAPEUTICS - SCIENTIFIC RATIONALE AND THE PROMISING APPROACHES TO THE TREATMENT OF THE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTEDINDIVIDUAL, Clinical infectious diseases, 17(4), 1993, pp. 749-771
TREATMENT RESEARCH PRIORITIES FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: PETTINELLI CB SCHNITTMAN SM
Citation: Cb. Pettinelli et Sm. Schnittman, TREATMENT RESEARCH PRIORITIES FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Infectious agents and disease, 2(5), 1993, pp. 291-303
SUMMARY OF THE NATIONAL-INSTITUTES-OF-HEALTH WORKSHOP ON PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: NIU MT JERMANO JA REICHELDERFER P SCHNITTMAN SM
Citation: Mt. Niu et al., SUMMARY OF THE NATIONAL-INSTITUTES-OF-HEALTH WORKSHOP ON PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, AIDS research and human retroviruses, 9(9), 1993, pp. 913-924
REPORT ON THE THERAPEUTIC VACCINE WORKSHOP - NATIONAL-COOPERATIVE-VACCINE-DEVELOPMENT-GROUP MEETING
Authors: GRADON JD SCHOOLEY RT SCHNITTMAN SM
Citation: Jd. Gradon et al., REPORT ON THE THERAPEUTIC VACCINE WORKSHOP - NATIONAL-COOPERATIVE-VACCINE-DEVELOPMENT-GROUP MEETING, AIDS research and human retroviruses, 9, 1993, pp. 190000055-190000058
PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - REVIEW OF PATHOGENESIS AND EARLY TREATMENT INTERVENTION IN HUMANS AND ANIMAL RETROVIRUS INFECTIONS
Authors: NIU MT STEIN DS SCHNITTMAN SM
Citation: Mt. Niu et al., PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION - REVIEW OF PATHOGENESIS AND EARLY TREATMENT INTERVENTION IN HUMANS AND ANIMAL RETROVIRUS INFECTIONS, The Journal of infectious diseases, 168(6), 1993, pp. 1490-1501
TREATMENT TRIALS FOR PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
Authors: NIU MT STEIN DS SCHNITTMAN SM
Citation: Mt. Niu et al., TREATMENT TRIALS FOR PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The Journal of infectious diseases, 168(6), 1993, pp. 1601-1602
Risultati: 1-15 |